Skip to main content


Particle Characterization For All Biotherapeutics

Fully configured to support applications across protein, antibody, cell, and gene therapy workflows, Aura+ brings particle characterization to earlier stages of therapeutic development, so you can make better decisions sooner.

Request a Quote

Particle Identification

5 µL to 10 mL Volume

1 Minute Per Sample

High Magnification Imaging

Why Choose Aura+?

When you need the flexibility to conduct particle characterization analyses on different types of biologics, including protein and antibody therapeutics, cell therapies, and gene therapies, the Aura+ has got you covered.

Powered by the Backgrounded Membrane Imaging (BMI) and Fluorescence Membrane Microscopy (FMM) technology shared within Aura family instruments, Aura+ enables applications from late discovery to development and manufacturing, enhancing decision-making and accelerating your success.

Analyze small volumes. The minimum sample volume is just 5 µL, enabling particle characterization earlier in the development timeline when sample volumes can be limited.

Gain insight quickly. With a 96-well membrane plate and the ability to analyze one sample every minute, the Aura+ takes you from labeled samples to data in as little as 90 minutes.

See Clearer With High Magnification

With the high magnification capabilities of the Aura+, you can see more morphological detail of unlabeled particles, enabling decisive discrimination between your lead and undesirable particles.

Quickly differentiate and enumerate cells versus Dynabeads, quantify polysorbate degradation, and more.

*Dynabeads refers to the magnetic beads produced by Thermo Fisher Scientific, Inc. Halo Labs is not affiliated with Thermo Fisher Scientific, Inc., and references to Dynabeads or any other third-party trademark do not imply sponsorship, endorsement, or approval.